Citigroup Maintains Buy on Boston Scientific, Raises Price Target to $87
Portfolio Pulse from Benzinga Newsdesk
Citigroup analyst Joanne Wuensch maintains a Buy rating on Boston Scientific (NYSE:BSX) and raises the price target from $85 to $87.
May 22, 2024 | 5:24 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Citigroup analyst Joanne Wuensch maintains a Buy rating on Boston Scientific and raises the price target from $85 to $87.
The Buy rating and increased price target from a reputable analyst at Citigroup is likely to positively impact investor sentiment and drive short-term price appreciation for Boston Scientific.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100